A3480

Atosiban

≥98% (HPLC)

• Sinónimos: 1-(3-Mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithineoxytocin, 1-Deamino-2-D-Tyr-(O-ethyl)-4-Thr-8-ornoxytocin, Tractocile
• Fórmula empírica (notación de Hill): C₄₃H₆₇N₁₁O₁₂S₂
• Número de CAS: 90779-69-4
• Peso molecular: 994.19
• Número MDL: MFCD00672436
• Código UNSPSC: 51111800
• ID de la sustancia en PubChem: 24724390
• NACRES: NA.77

Propiedades

• Ensayo: ≥98% (HPLC)
• Formulario: lyophilized powder
• condiciones de almacenamiento: desiccated
• color: white
• solubilidad: H₂O: ≤100 mg/mL
• emisor: Ferring
• Condiciones de envío: wet ice
• temp. de almacenamiento: −20°C
• cadena SMILES: [H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](Cc2ccc(OCC)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
• InChI: 1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36-/m0/s1
• Clave InChI: VWXRQYYUEIYXCZ-OBIMUBPZSA-N
• Información sobre el gen: human ... AVPR1A(552) , OXTR(5021) ; rat ... Oxtr(25342)

Descripción

Aplicación

Atosiban has been used:

• as an oxytocin receptor antagonist[1]
• in the calcium mobilization assay for Z factor determination in uterine myometrium (UT-myo cells) and as a therapeutic agent to inhibit preterm labor[2]
• to inhibit the activation of oxytocin-receptor-expressing neurons in the parabrachial nucleus of mice (Oxtr^PBN)[3]

Acciones bioquímicas o fisiológicas

Atosiban efficiently prevent preterm uterine contractions without any major cardiovascular, pulmonary or central nervous system side effects.[4] It has potential to treat preterm labour.[4][5]

Atosiban is a peptide oxytocin receptor antagonist.

Características y beneficios

This compound was developed by Ferring. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Reconstitución

Reconstitute in deionized water at not less than 100 μg/mL, which can then be diluted into aqueous vehicle of choice. Solutions may be stored at 2-8 °C for up to seven days. For extended storage, add a carrier protein of 0.1% human serum albumin or bovine serum albumin and freeze in working aliquots at −20 °C.

Información de seguridad

• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3
• Punto de inflamabilidad (°F): Not applicable
• Punto de inflamabilidad (°C): Not applicable